MAM
Meeder Asset Management Portfolio holdings
AUM
$1.63B
1-Year Return
27.94%
This Quarter Return
+15.27%
1 Year Return
+27.94%
3 Year Return
+116.82%
5 Year Return
+187.4%
10 Year Return
+462.19%
AUM
$1.58B
AUM Growth
+$300M
(+23%)
Cap. Flow
+$158M
Cap. Flow
% of AUM
9.97%
Top 10 Holdings %
Top 10 Hldgs %
35.12%
Holding
822
New
356
Increased
160
Reduced
158
Closed
78
Top Buys
| 1 |
Meta Platforms (Facebook)
META
|
$26.3M |
| 2 |
Johnson & Johnson
JNJ
|
$16.1M |
| 3 |
Lennar Class A
LEN
|
$15.9M |
| 4 |
Texas Instruments
TXN
|
$15.3M |
| 5 |
iShares Short Treasury Bond ETF
SHV
|
$13.3M |
Top Sells
| 1 |
Microsoft
MSFT
|
$30.1M |
| 2 |
AbbVie
ABBV
|
$21.1M |
| 3 |
Amgen
AMGN
|
$17.1M |
| 4 |
Adobe
ADBE
|
$16.9M |
| 5 |
UnitedHealth
UNH
|
$10.5M |
Sector Composition
| 1 | Technology | 27.78% |
| 2 | Financials | 14.74% |
| 3 | Consumer Discretionary | 11.75% |
| 4 | Industrials | 9.02% |
| 5 | Healthcare | 8.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
601
GE HealthCare
GEHC
$34.6B
| $7K | ﹤0.01% |
+77
| New | +$7K |
|
602
Paychex
PAYX
$48.7B
| $7K | ﹤0.01% |
+57
| New | +$7K |
|
603
Biogen
BIIB
$20.6B
| $6.9K | ﹤0.01% |
+32
| New | +$6.9K |
|
604
LPL Financial
LPLA
$26.6B
| $6.87K | ﹤0.01% |
+26
| New | +$6.87K |
|
605
BioMarin Pharmaceuticals
BMRN
$11.1B
| $6.81K | ﹤0.01% |
+78
| New | +$6.81K |
|
606
Estee Lauder
EL
$32.1B
| $6.63K | ﹤0.01% |
+43
| New | +$6.63K |
|
607
Neurocrine Biosciences
NBIX
$14.3B
| $6.62K | ﹤0.01% |
+48
| New | +$6.62K |
|
608
Utah Medical Products
UTMD
$203M
| $6.47K | ﹤0.01% |
+91
| New | +$6.47K |
|
609
Archer Daniels Midland
ADM
$30.2B
| $6.41K | ﹤0.01% |
+102
| New | +$6.41K |
|
610
Avantor
AVTR
$9.07B
| $6.39K | ﹤0.01% |
+250
| New | +$6.39K |
|
611
Keurig Dr Pepper
KDP
$38.9B
| $6.38K | ﹤0.01% |
+208
| New | +$6.38K |
|
612
Five Below
FIVE
$8.46B
| $6.35K | ﹤0.01% |
+35
| New | +$6.35K |
|
613
MasTec
MTZ
$14B
| $6.34K | ﹤0.01% |
+68
| New | +$6.34K |
|
614
Cato Corp
CATO
$87.2M
| $6.28K | ﹤0.01% |
+1,089
| New | +$6.28K |
|
615
Church & Dwight Co
CHD
$23.3B
| $6.26K | ﹤0.01% |
+60
| New | +$6.26K |
|
616
Royalty Pharma
RPRX
$15.6B
| $6.2K | ﹤0.01% |
+204
| New | +$6.2K |
|
617
Wayfair
W
$11.6B
| $6.18K | ﹤0.01% |
+91
| New | +$6.18K |
|
618
Roku
ROKU
$14B
| $6.13K | ﹤0.01% |
+94
| New | +$6.13K |
|
619
Tenet Healthcare
THC
$17.3B
| $5.89K | ﹤0.01% |
+56
| New | +$5.89K |
|
|
ITCI
620
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $5.81K | ﹤0.01% |
+84
| New | +$5.81K |
|
621
McCormick & Company Non-Voting
MKC
$19B
| $5.76K | ﹤0.01% |
+75
| New | +$5.76K |
|
622
KLX Energy Services
KLXE
$33.7M
| $5.76K | ﹤0.01% |
744
| – | – |
|
623
Rockwell Automation
ROK
$38.2B
| $5.54K | ﹤0.01% |
+19
| New | +$5.54K |
|
624
Rivian
RIVN
$17.2B
| $5.45K | ﹤0.01% |
+498
| New | +$5.45K |
|
625
Xylem
XYL
$34.2B
| $5.43K | ﹤0.01% |
+42
| New | +$5.43K |
|